Search Results 31-40 of 17131 for egfr

  1. Amivantamab and hyaluronidase-lpuj (subcutaneous route) - Side effects & uses - Mayo Clinic

    ... (EGFR) gene (exon 19 deletions or exon 21 L858R substitution mutations). This medicine is also used in combination with carboplatin and pemetrexed to treat ...

  2. Mayo Clinic opens new doors in cancer treatment innovation

    These include human epidermal growth factor receptor 2 (HER2), epidermal growth factor receptor (EGFR), and mesenchymal-epithelial transition factor (MET).

  3. Clinical trials - Lung Cancer Program

    Patients with known EGFR (Epidermal growth factor receptor) tyrosine kinase (TK) activating mutations and anaplastic lymphoma kinase (ALK) rearrangements ...

  4. A Phase 2, Multicenter, Study of Ficlatuzumab Plus Erlotinib Versus Placebo Plus Erlotinib in Subjects Who Have Previously Untreated Metastatic, EGFR-mutated Non-small Cell Lung Cancer (NSCLC) and BDX004 Positive Label - Mayo Clinic

    A Phase 2, Multicenter, Study of Ficlatuzumab Plus Erlotinib Versus Placebo Plus Erlotinib in Subjects Who Have Previously Untreated Metastatic, EGFR ...

  5. Cancer-Causing Gene Alone Doesn't Trigger Pancreatic Cancer, Mayo-led Study Finds

    ... EGFR.A third genetic participant known as Trp53 makes pancreatic tumors very difficult to treat, the study showed. The scientists also found that EGFR was ...

  6. A Study Of Amivantamab In Combination With Lazertinib, Or Amivantamab In Combination With Platinum-Based Chemotherapy, For Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung Cancer (NSCLC) - Mayo Clinic

    ... (EGFR)-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung Cancer (NSCLC). Print details. Share; Facebook · Twitter. Overview; Participation eligibility ...

  7. Hemodialysis - Mayo Clinic

    Your doctor uses your estimated glomerular filtration rate (eGFR) to measure your level of kidney function. Your eGFR is calculated using your blood ...

  8. Hematology - Clinical trials

    Additional patients limited to those with EGFR mutations may be enrolled following the initial study period as needed to ensure adequate sample sizes needed to ...

  9. A Study To Evaluate The Safety And Efficacy Of A2B395, An Allogeneic Logic-gated CAR T, In Participants With Solid Tumors That Express EGFR And Have Lost HLA-A*02 Expression - Mayo Clinic

    A Study To Evaluate The Safety And Efficacy Of A2B395, An Allogeneic Logic-gated CAR T, In Participants With Solid Tumors That Express EGFR And Have Lost HLA-A* ...

  10. End-stage renal disease - Symptoms and causes - Mayo Clinic

    When kidneys no longer function well enough to meet a body's needs, treatment involves kidney dialysis or kidney transplant.